Endoluminal Suturing Devices Market By Product Type (Single-use Devices, Reusable Devices, Suturing Accessories), By Application (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Treatment, Colorectal Surgery, Others), , By Technology (Manual Suturing Devices, Robotic-Assisted Suturing Devices, Advanced Suturing Platforms),By End-User (Hospitals, Ambulatory Surgical Centre, Specialized Clinics) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Endoluminal Suturing Devices market accounted for USD 93.2 Million in 2024 and is expected to reach USD 302.6 Million by 2035, growing at a CAGR of around 11.3% between 2025 and 2035. The Endoluminal Suturing Devices Market is the sector of the economy that supplies materials, produces, distributes, and sells the tools needed to suture bodily tissues using the Endoluminal Suturing Technique. The primary use of these devices is Endoluminal Surgery, which involves operating on the organ's internal walls and cavities as well as through tiny through-holes and natural orifices.

Endoluminal Suturing Devices are particularly helpful because of their advantageous properties, such as their rapid recovery time and minimal scarring. Dedication has increased in a variety of surgical procedures. In contrast to traditional open surgery, they have advantages like a shorter recovery period and fewer scars as compared to laparoscopic surgery.

Report Scope:

Market Dynamics:

The increasing global obesity epidemic is driving demand for minimally invasive bariatric procedures using suturing devices.

Global Obesity Epidemic, a universal problem that has reached pandemic proportions, has especially spurred demand for bariatric surgeries carried out mostly via the minimally invasive approach. These procedures call for specialized suture tools to be applied to activities such as gastric bypass or sleeve gastrectomy based on the tender and sensitive tissue of the patient. Endoluminal Suturing Devices make it possible for surgeons to perform these procedures using small ports, hence less postoperative tissue healing time, minimal scarring, and better surgical results. The increasing trends of obesity therefore require better and improved instruments, equipment, and technology such as endoluminal sifting devices for ABS. The global obesity rate has nearly tripled since 1975 as stated by the World Health Organization and currently, more than 650 million adults are considered obese. The growing health problem of obesity has seen more focus placed on weight loss surgery thus growing demand for technologies like endoluminal suturing devices. The changing status of bariatric surgery and the increasing embrace of obesity as a valid solution also bodes well for the Endoluminal Suturing Devices Market.

Surgeons and patients prefer endoluminal suturing because it reduces recovery time, lowers pain, and causes minimal scarring.

Patients and surgeons have expressed a preference for Endoluminal Suturing Devices due to their advantages over open surgeries. The main benefits include reduced pain following the procedure, less scarring, and shorter recovery times. Endoluminal procedures utilize small or natural openings in the body, which results in less trauma to surrounding tissues. This approach leads to faster recovery, decreased risks, and an improved ability for patients to return to normal activities more quickly than traditional surgery.

Additionally, the possibility of infection and surgical scarring is reduced, making this procedure favorable for both patients and surgeons. A study conducted by the American Society for Metabolic and Bariatric Surgery found that minimally invasive bariatric surgeries, which often use endoluminal suturing, result in negligible post-operative pain and scarring. This explains the growing popularity of these techniques in modern surgeries.

The high capital investment and maintenance costs of robotic suturing devices limit accessibility for smaller centers.

One of the strongest threats that are seen to hinder the growth of the Endoluminal Suturing Devices Market is the high capital costs of the operating equipment and an equally high cost of maintenance. Such sophisticated solutions entail significant initial expenditures, and it could be a major challenge for relatively small healthcare facilities, especially in the developing world or where overall healthcare expenditure remains low.

Furthermore, sustaining and updating robotic systems and also the costs of staff training, parts, and services consequently puts pressure on financial management. Therefore, a small clinic which is a single specialty center or a small hospital will not be able to afford the cost, which in turn makes them unable to get the newest technologies such as robotic suturing devices.

Untapped regions like Asia-Pacific and Latin America present significant growth potential due to rising healthcare investments.

Some of the growth opportunities in the Endoluminal Suturing Devices market include Asia-Pacific and Latin America where the health care investment is still in its infancy. The governments and the private sectors of these regions are now concentrating and allocating substantial capital to developing the healthcare infrastructures, extending access to advanced medical technologies, and catering the higher healthcare needs. Increasing incidences of chronic diseases related to obesity, possible gastrointestinal diseases, and colorectal cancer also propel the demand for the utilization of minimally invasive surgical tools and the techniques of applying endoluminal suturing systems. The increasing demand for qualitative and economical surgical products among these regions can be seen as the major market potential for endoluminal suturing devices.

Developing eco-friendly, biodegradable sutures could attract healthcare providers focused on sustainable solutions:

The eco-friendly and biodegradable sutures are likely to open up a promising avenue in the endoluminal suturing devices market. Since healthcare facilities are sensitizing their practice towards sustainability, these sutures are well suited to the rising market of sustainable healthcare products. Cohesive sutures do not last forever, thereby reducing medical waste as well as the impacts of surgery on the natural environment. They also have advantages like decreased risk of inflammation and no need to take time in the removal of sutures, making the patient’s experience better.

This innovation could be of interest to hospitals or clinics that wish to attain sustainability objectives as they deliver quality services. The use of biodegradable options enables the development of new products that can capture the market of consumers who are conscious of their environment and the intermediate impacts of their decisions. Such a change may foster market development due to growing concerns about healthcare institutions and centers’ sustainability.

Industry Expert's Opinion:

"Endoluminal suturing devices represent a significant advancement in minimally invasive gastrointestinal procedures. These devices enhance the precision and safety of endoscopic treatments, providing patients with effective alternatives to traditional surgery for conditions like GERD and bariatric revisions. Their growing adoption is a testament to their ability to reduce recovery times and improve clinical outcomes."

• Dr. Michael Thompson, MD, Chief of Gastroenterology at Central Medical Center

Segment Analysis:

Based on the product type, the Endoluminal Suturing Devices Market has been classified into Single-Use Devices, Reusable Devices, and Suturing Accessories. Single-use Devices product type is currently the largest segment in the Endoluminal Suturing Devices Market worldwide. This dominance can be attributed to several factors such as hygiene, which has improved, is easy to control, and hardly one gets an infection from it. They are used once, or in other words they are disposable, this aspect is favorable when performing endoluminal operations hence, the need to use a different instrument every time there is an operation. In addition, single-use devices do not require cleaning and subsequent sterilization; they are therefore more beneficial to healthcare workers; they are cheaper to maintain.  

Based on the Application, the Endoluminal Suturing Devices Market has been classified into Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Treatment, Colorectal Surgery, and Others. Within the applications of the Endoluminal Suturing Devices Market, the Bariatric Surgery segment is the largest of all. This dominance is due to an increase in global obesity and an increase in utilization of weight-reduction operations including gastric bypass and sleeve gastrectomy.

Superficial suturing in bariatric surgery is demanding for the necessary impact, and endoluminal suturing devices correspond to the requirements of minimally invasive procedures. Technological advancement in bariatric surgery, resulting in the introduction of minimally invasive procedures that are characterized by fewer injuries and a faster rate of recovery among other benefits including; shorter hospitalization, less pain, and smaller incisions also drive the demand for these specialized suturing devices.

Regional Analysis

Because of high-tech healthcare systems, the high prevalence of the adoption of innovative technologies, and the region’s emphasis on minimally invasive surgeries, North America dominates in the Endoluminal Suturing Devices Market. The US is one of the largest contributors, due to a high volume of bariatric, gastrointestinal, and colorectal surgeries done annually, all of which utilize endoluminal suture delivery systems. The reimbursement policies for the respective medical procedures have long been in place across the region and the obesity trends have risen gradually adding to the demand for these devices. Furthermore, North America is tops in healthcare measures and has big manufacturers of medical devices to complete its dominion. North America will continue to dominate the market due to the increasing innovations and developing surgical technologies.

The Endoluminal Suturing Devices Market is in the growing stage in the Asia-Pacific region due to strong investment in healthcare and better access to the latest technologies. There is an increasing trend in demand for Laparoscopic, bariatric gastrointestinal, and colorectal procedures in countries like China, India, and Japan where endoluminal suturing apparatuses are used. Factors that favor these markets include the increased prevalence of obesity, increased awareness of the benefits of minimally invasive procedures, and the increase in the overall healthcare infrastructure. Also, it is statistically becoming formally recognized as a significant medical tourism destination, hence promoting the use of enhanced surgical tools. The prevalence of government support in enhancing health systems and developments in healthcare technologies contributed to Asia-Pacific as expected to remain the fastest-growing market.

Competitive Landscape

The market players involved in the manufacturing and distribution of Endoluminal Suturing Devices are strategic in their offerings to financial and operational competitive capabilities of Endoluminal Suturing Devices Market products and services.

The market remains moderately concentrated since both the giants like big-name multinationals and upcoming strong rivals are in a constant race to provide superior technology, diversifying their product lines, and concentrating on partnerships and acquisitions. Below is an overview of some key players and their strategies in the market: Apollo Endosurgery, Inc., Medtronic plc, Ethicon (Johnson & Johnson), Olympus Corporation, Endo-Gastric Solutions, Boston Scientific Corporation, Ovesco Endoscopy AG, STERIS plc, Cook Medical, Stryker Corporation, Conmed Corporation, Smith & Nephew plc, Fujifilm Holdings Corporation, Interscope, Inc.

Endoluminal Suturing Devices Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

In November 2023, Ethicon, a division of Johnson & Johnson MedTech, introduced the ETHIZIA Hemostatic Sealing Patch, designed to manage challenging bleeding scenarios effectively. This cutting-edge patch features a unique synthetic polymer technology, making it the first hemostatic matrix that functions equally well on both sides. It has received CE Mark approval for use on internal organs, except for cardiovascular and neurological applications.

Report Coverage:

By Product Type

• Single-use Devices
• Reusable Devices
• Suturing Accessories

 By Application

• Bariatric Surgery
• Gastrointestinal Surgery
• Gastroesophageal Reflux Disease Treatment
• Colorectal Surgery
• Others

By Technology

• Manual Suturing Devices
• Robotic-Assisted Suturing Devices
• Advanced Suturing Platforms

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:                                                      

• Apollo Endosurgery, Inc.
• Medtronic plc
• Ethicon (Johnson & Johnson)
• Olympus Corporation
• Endo-Gastric Solutions
• Boston Scientific Corporation
• Ovesco Endoscopy AG
• STERIS plc
• Cook Medical
• Stryker Corporation
• Conmed Corporation
• Smith & Nephew plc
• Fujifilm Holdings Corporation
• Interscope, Inc.
• PENTAX Medical

Frequently Asked Questions (FAQs)